Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-21-008899

Chief Financial Officer acquired 3,534 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jorgensen Nathan D. Chief Financial Officer 2021-02-09 Conversion +3,534 29,269 D
Derivatives
Jorgensen Nathan D. Chief Financial Officer 2021-02-09 Conversion · Series B Preferred Stock −48,076 0 D
Loading xslF345X03/doc4.xml…